Trials / Completed
CompletedNCT02007655
Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,372 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objectives of this study are: * To estimate the incidence rate of unexpected adverse events * To characterize the bleeding events and assess risk factors of bleeding * To identify ancillary baseline variables that may also be associated with adverse outcomes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eliquis |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2016-08-31
- Completion
- 2016-08-31
- First posted
- 2013-12-11
- Last updated
- 2022-06-07
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02007655. Inclusion in this directory is not an endorsement.